Editorial: A Novel Monoclonal Antibody-Targeting Angiogenesis by Inhibiting Secreted Frizzled-Related Protein 2.
作者信息
Lang Julie E, Tseng William W, Kang Irene
机构信息
Division of Surgical Oncology, Department of Surgery, University of Southern California, Los Angeles, CA, USA.
University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
出版信息
Ann Surg Oncol. 2019 Dec;26(13):4188-4190. doi: 10.1245/s10434-019-07801-1. Epub 2019 Sep 9.
Abstract
摘要
相似文献
1
Editorial: A Novel Monoclonal Antibody-Targeting Angiogenesis by Inhibiting Secreted Frizzled-Related Protein 2.社论：一种通过抑制分泌型卷曲相关蛋白2靶向血管生成的新型单克隆抗体
Ann Surg Oncol. 2019 Dec;26(13):4188-4190. doi: 10.1245/s10434-019-07801-1. Epub 2019 Sep 9.
2
Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth.抗连接黏附分子C抗体可抑制血管生成和肿瘤生长。
Cancer Res. 2005 Jul 1;65(13):5703-10. doi: 10.1158/0008-5472.CAN-04-4012.
3
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy.贝伐单抗（阿瓦斯汀），一种用于癌症治疗的人源化抗血管内皮生长因子单克隆抗体。
Biochem Biophys Res Commun. 2005 Jul 29;333(2):328-35. doi: 10.1016/j.bbrc.2005.05.132.
4
Effects of TNF-α inhibitors upon the mechanisms of action of VEGF.肿瘤坏死因子-α抑制剂对血管内皮生长因子作用机制的影响。
Immunotherapy. 2013 Feb;5(2):113-5. doi: 10.2217/imt.12.151.
5
A novel monoclonal antibody to secreted frizzled-related protein 2 inhibits tumor growth.一种新型的针对分泌型卷曲相关蛋白 2 的单克隆抗体抑制肿瘤生长。
Mol Cancer Ther. 2013 May;12(5):685-95. doi: 10.1158/1535-7163.MCT-12-1066. Epub 2013 Apr 19.
6
Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development.抗 Gb3 单克隆抗体抑制血管生成和肿瘤发展。
PLoS One. 2012;7(11):e45423. doi: 10.1371/journal.pone.0045423. Epub 2012 Nov 26.
7
Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis.抑制内皮细胞 SCUBE2（信号肽-CUB-EGF 结构域蛋白 2），一种新型的 VEGFR2（血管内皮生长因子受体 2）辅助受体，可抑制肿瘤血管生成。
Arterioscler Thromb Vasc Biol. 2018 May;38(5):1202-1215. doi: 10.1161/ATVBAHA.117.310506. Epub 2018 Mar 15.
8
MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models.MEDI3617，一种人源抗血管生成素 2 单克隆抗体，可抑制人肿瘤异种移植模型中的血管生成和肿瘤生长。
Int J Oncol. 2012 May;40(5):1321-30. doi: 10.3892/ijo.2012.1366. Epub 2012 Feb 10.
9
Blockade of delta-like ligand 4 signaling inhibits both growth and angiogenesis of pancreatic cancer.阻断 Delta 样配体 4 信号通路可抑制胰腺癌的生长和血管生成。
Pancreas. 2010 Aug;39(6):897-903. doi: 10.1097/MPA.0b013e3181ce7185.
10
[Bevacizumab].[贝伐单抗]
Rev Infirm. 2009 Jan-Feb(147):46-8.
本文引用的文献
1
Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo.一种新型人源化单克隆抗体对分泌型卷曲相关蛋白 2 的开发，该抗体可抑制体内三阴性乳腺癌和血管肉瘤的生长。
Ann Surg Oncol. 2019 Dec;26(13):4782-4790. doi: 10.1245/s10434-019-07800-2. Epub 2019 Sep 12.
2
Development of mouse models of angiosarcoma driven by p53.p53 驱动的血管肉瘤小鼠模型的建立。
Dis Model Mech. 2019 Jul 9;12(7):dmm038612. doi: 10.1242/dmm.038612.
3
Decreased local and systemic levels of sFRP3 protein in osteosarcoma patients.骨肉瘤患者局部和全身 sFRP3 蛋白水平降低。
Gene. 2018 Oct 20;674:1-7. doi: 10.1016/j.gene.2018.06.059. Epub 2018 Jun 19.
4
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.利用抗血管生成药物增强癌症免疫治疗：机遇与挑战。
Nat Rev Clin Oncol. 2018 May;15(5):325-340. doi: 10.1038/nrclinonc.2018.29. Epub 2018 Mar 6.
5
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa.用抗血管生成治疗来改善免疫疗法的结果，反之亦然。
Nat Rev Clin Oncol. 2018 May;15(5):310-324. doi: 10.1038/nrclinonc.2018.9. Epub 2018 Feb 13.
6
A pathology atlas of the human cancer transcriptome.人类癌症转录组病理学图谱。
Science. 2017 Aug 18;357(6352). doi: 10.1126/science.aan2507.
7
Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review.用于实体瘤治疗的抗血管生成药物：潜在途径、治疗方法及当前策略——综述
J Adv Res. 2017 Nov;8(6):591-605. doi: 10.1016/j.jare.2017.06.006. Epub 2017 Jun 27.
8
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?癌症抗血管生成再探讨：与免疫疗法联合使用是否有作用？
Angiogenesis. 2017 May;20(2):185-204. doi: 10.1007/s10456-017-9552-y. Epub 2017 Mar 30.
9
The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma.融合蛋白SS18-SSX1利用核心Wnt信号通路转录因子在滑膜肉瘤中诱导出部分Wnt信号特征。
Sci Rep. 2016 Feb 24;6:22113. doi: 10.1038/srep22113.
10
Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.通过全外显子组测序和基因组分析，在韧带样型纤维瘤病中几乎普遍检测到CTNNB1和Wnt信号通路调节因子的改变。
Genes Chromosomes Cancer. 2015 Oct;54(10):606-15. doi: 10.1002/gcc.22272. Epub 2015 Jul 14.
Zotero 插件